Sleep deprivation and bright light as potential augmenters of antidepressant drug treatment-Neurobiological and psychometric assessment of course

Journal of Psychiatric Research

Volumn 28, Issue 4, 1994, Pages 381-399

  Holsboer Trachsler, E ^a   Hemmeter, U ^a   Hatzinger, M ^a   Seifritz, E ^a   Gerhard, U ^a   Hobi, V ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; TRIMIPRAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIGHT; MALE; NEUROBIOLOGY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER;

ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; COMBINED MODALITY THERAPY; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PHOTOTHERAPY; PITUITARY-ADRENAL SYSTEM; POLYSOMNOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SLEEP DEPRIVATION; TRIMIPRAMINE;

EID: 0028151636     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-3956(94)90020-5     Document Type: Article

References (59)

1. Prolongation of antidepressant response to partial sleep deprivation by lithium
2. Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression
3. Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes
4. Maintenance of therapeutic effects of total sleep deprivation by limitation of subsequent sleep
5. Repeated partial sleep deprivation progressively changes the EEG during sleep and wakefulness
6. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression
7. Sleep deprivation and clomipramine in endogenous depression
8. Clinical effect of sleep deprivation and clomipramine in endogenous depression
9. Clinical originality and new biology of trimipramine
10. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology
11. Exactly what does the Hamilton Depression Rating Scale measure?
12. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline
13. Dexamethasone suppression tests in antidepressant treatment of melancholia — the process of normalization and test-retest reproducibility
14. Development of a rating scale for primary depressive illness
15. Apparative Test
16. A new device for testing cognitive-psychomotor functions. A line tracking apparatus (LTA) by Amrein, R.A comparative study
17. Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder
18. The hypothalamic-pituitary-adrenocortical system
19. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression—implications for pathophysiology of DST non-suppress ion
20. Repeated dexamethasone suppression test during depressive illness. Normalization of test results compared with clinical improvement
21. The dexamethasone-hCRH stimulation test and cognitive performance during antidepressive treatment with trimipramine
22. Der biologische Zugang schwer zu behandelnder Depressionen
23. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression
24. Serial partial sleep deprivation in depression — Clinical effects and dexamethasone suppression test results
25. Thyroid hormone use to enhance the effects of drugs
26. The difficult depressed patient in perspective
27. REM latency: A psychobiologic marker for primary depressive disease
28. Depression, EEG sleep and clinical response
29. Sleep and treatment prediction in endogenous depression
30. Recent diagnostic and treatment advances in REM sleep and depression
31. From early to late adulthood changes in EEG sleep of depressed patients and healthy volunteers
32. Age, REM sleep, and depression
33. Is sleep deprivation useful in the treatment of depression?
34. Bright light augmentation in antidepressant nonresponders
35. Combined sleep deprivation and clomipramine in primary depression
36. A new depression scale designed to be sensitive to changes
37. Physiology and pharmacology of corticotropin-releasing factor
38. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures
39. Bipolar-unipolar distinction
40. Enhancement of imipramine antidepressant activity by thyroid hormone
41. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
42. Sleep architecture in seasonal affective disorder: the effects of light therapy and changing seasons
43. Polysomnographic findings in recently drug-free and clinically remitted depressed patients
44. Effects of morning versus evening bright light exposure on REM latency
45. Biologisch aktives Licht, ein Adjuvans in der Behandlung therapieresistenter endogener Depression
46. Die Therapie der depressiven Insomnie durch seriellen partiellen Schlafentzug
47. Sleep-EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery
48. Sleep-electroencephalography and the secretion of cortisol and growth hormone in normal controls
49. Drug combinations in the treatment of refractory depression: A review
50. Light therapy for seasonal affective disorder: a review of efficacy
51. Antidepressants and memory: A review
52. Action of trimipramine on sleep and pituitary hormone secretion